The Role of Modified Ultrafiltration Following Open Heart Surgery

Sponsor
Indonesia University (Other)
Overall Status
Completed
CT.gov ID
NCT06085066
Collaborator
(none)
38
1
2
8
4.7

Study Details

Study Description

Brief Summary

This study aims to investigate the effect of combining conventional ultrafiltration and modified ultrafiltration compared to conventional ultrafiltration alone in patients who underwent open heart surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Conventional Ultrafiltration alone on Cardiopulmonary bypass
  • Procedure: Conventional Ultrafiltration followed by Modified Ultrafitration on Cardiopulmonary bypass
N/A

Detailed Description

The target of this study is adult patients diagnosed with coronary heart disease and valve disease who underwent open heart surgery in CICU PJT RSCM and Jakarta Heart Hospital. The research was conducted after obtaining approval from the FKUI-RSCM ethical committee, and the research subjects agreed to participate by signing an informed consent form. The anesthesia team prepared research subjects undergoing surgery with the placement of arterial cannulas, central venous catheters, sheath introducers, pulmonary artery catheters, and anesthesia management. The placement of these instruments aimed at measuring dependent variables studied included Systemic Vascular Resistance (SVR), Pulmonary Vascular Resistance (PVR), Cardiac Index (CI), and IL-6 levels. The CPB machine was used during the heart chamber opening procedure or coronary artery graft placement, and CUF was initiated. After CPB use was concluded, research subjects were allocated to either the control group or the treatment group through randomization. MUF was performed post-CPB in the treatment group, with the pump speed not exceeding 10% of full flow for 10 minutes. IL-6 levels were measured twice, namely before induction of anesthesia and 24 hours after CPB. SVR, PVR, and CI measurements were carried out before CPB, post-CPB, 10 minutes post-CPB, and 24 hours post-CPB.

Study Design

Study Type:
Interventional
Actual Enrollment :
38 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Official Title:
The Role of Modified Ultrafiltration on Vascular Resistance, Cardiac Index Enhancement, and Inflammation Reduction Following Open Heart Surgery; A Randomized Clinical Trial
Actual Study Start Date :
Jun 1, 2021
Actual Primary Completion Date :
Dec 31, 2021
Actual Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Conventional Ultrafiltration alone on Cardiopulmonary bypass

Conventional ultrafiltration was used on a cardiopulmonary bypass procedure for patients who underwent open heart surgery

Procedure: Conventional Ultrafiltration alone on Cardiopulmonary bypass
Conventional Ultrafiltration was used on Cardiopulmonary bypass for patients who underwent open heart surgery

Active Comparator: Conventional Ultrafiltration followed by Modified Ultrafitration on Cardiopulmonary bypass

Modified ultrafiltration was used following the conventional ultrafiltration on cardiopulmonary bypass procedure for patients who underwent open heart surgery

Procedure: Conventional Ultrafiltration followed by Modified Ultrafitration on Cardiopulmonary bypass
Modified Ultrafiltration was used following the Conventional Ultrafiltration on Cardiopulmonary bypass for patients who underwent open heart surgery

Outcome Measures

Primary Outcome Measures

  1. Interleukin-6 [24 hours]

    Comparison of IL-6 levels between combination conventional ultrafiltration and modified ultrafiltration with conventional ultrafiltration only on cardiopulmonary bypass. IL-6 levels were assessed using blood samples drawn through a Central Venous Catheter installed before the procedure. Elevated IL-6 levels are indicative of heightened inflammation in the patient, correlating with a more adverse outcome.

  2. Systemic Vascular Resistance (SVR) [24 hours]

    Comparison of SVR between combination conventional ultrafiltration and modified ultrafiltration with conventional ultrafiltration only on cardiopulmonary bypass. SVR is the aortic resistance value that the left heart must surpass to pump blood out effectively. SVR measurements are acquired by placing a Pulmonary Artery Catheter in the jugular vein, which is subsequently connected to a Philips monitor. This allows for automatic reading of SVR in dyne.sec/cm5 units through the monitor.

  3. Pulmonary Vascular Resistance (PVR) [24 hours]

    Comparison of PVR between combination conventional ultrafiltration and modified ultrafiltration with conventional ultrafiltration only on cardiopulmonary bypass. PVR is the pulmonary artery resistance value that the right heart must surmount to efficiently pump blood out. PVR measurements are derived from the insertion of a Pulmonary Artery Catheter via the jugular vein, which is subsequently linked to a Philips monitor, facilitating automated readings in units of dyne.sec/cm5 through the monitor.

  4. Cardiac Index [24 hours]

    Comparison of Cardiac Index between combination conventional ultrafiltration and modified ultrafiltration with conventional ultrafiltration only on cardiopulmonary bypass. The cardiac index (CI) represents the volume of blood continuously ejected from the left heart in one minute, relative to the body surface area. CI measurements are acquired through the insertion of a Pulmonary Artery Catheter via the jugular vein, which is subsequently linked to a Philips monitor. This allows for automatic readings in units of L/minute/m2. A higher CI value corresponds to a more favorable patient outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients aged 18 years or older undergoing elective open heart surgery

  • Willing to become a research participant and sign an informed consent statement

Exclusion Criteria:
  • Patients undergoing redo surgery and emergency surgery

  • Patients that have immune disease, chronic lung disease, undergoing hemodialysis

  • Patients who are pregnant

Drop-out Criteria

  • Patients who experience repeated back-on bypass

  • Patients who experience reopen surgery 24 hours after surgery

  • Patients who die within 24 hours after surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cipto Mangunkusumo Central National Hospital Jakarta Pusat DKI Jakarta Indonesia

Sponsors and Collaborators

  • Indonesia University

Investigators

  • Principal Investigator: Ratna F Soenarto, Consultant, Indonesia University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ratna Farida Soenarto, Consultant, Anestesiologist, Indonesia University
ClinicalTrials.gov Identifier:
NCT06085066
Other Study ID Numbers:
  • IndonesiaUAnes1000
First Posted:
Oct 16, 2023
Last Update Posted:
Oct 16, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ratna Farida Soenarto, Consultant, Anestesiologist, Indonesia University

Study Results

No Results Posted as of Oct 16, 2023